Claim library

Has FDA flagged "Alzheimer's"?

Yes. FDA has quoted wording matching "Alzheimer's" in at least 30 warning letters in our database. The most recent is FDA's August 24, 2026 letter to Peptide Partners LLC.

Checked against published FDA warning letters, updated November 15, 2026.

Letters that quote it

Each quote is copied from the company's marketing as FDA printed it in the letter.

[T]his laboratory study... suggests that semaglutide could have a protective effect on brain cells, which might be relevant for neurodegenerative diseases like Alzheimer’s.

Peptide Partners LLC, August 24, 2026
Read the FDA letter

Antioxidants can help reduce oxidative damage in brain cells, potentially lowering the risk of age-related cognitive decline and diseases like Alzheimer's.

OptiHealth Products, Inc., April 29, 2026
Read the FDA letter

PRYENDA prevents and reverses cognitive damage caused from prions and is a therapeutic treatment against TSEs and other neurodegenerative diseases like Alzheimer’s and Parkinson’s disease.

Intelligent Remedies, Inc., January 23, 2026
Read the FDA letter

Medical Studies Have Demonstrated (And As Confirmed By Online Reviews About Testolone) That RAD-140 Is Highly Effective To Treat Degenerative Conditions Like Alzheimer's Disease. It Is Equally Effective To Provide Relief To Subjects With Androgenic Deficiencies.

Prime Sports Nutrition, December 12, 2025
Read the FDA letter

Dr. Reckeweg Germany Nux Mosch Dilution 10M CH is primarily used for the treatment of allergy, symptoms related to Alzheimer's Disease, colic, confusion, weak memory, sore throat, constipation and vertigo.

Mahita LLC dba PushMyCart, November 17, 2025
Read the FDA letter

Neuroprotective Potential: Emerging evidence suggests that semaglutide peptide may possess neuroprotective properties, offering potential benefits in neurodegenerative diseases such as Alzheimer’s disease.

Xcel Research LLC, December 10, 2024
Read the FDA letter

CBD may protect nerve cells from deteriorating, and a study from Frontiers in Pharmacology found that CBD can significantly decrease the negative effects of Alzheimer[’]s and also improve cognitive ability.

Root Bioscience Brands, LLC dba Naternal, August 30, 2024
Read the FDA letter

Neuroprotection: Kava has preventive properties against strokes. Two of Kava's constituents, dihydromethysticin and methysticin, have similar potency to the Alzheimer's disease treatment Memantine.

Shot of Joy LLC, September 25, 2023
Read the FDA letter

Moderate Conditions Lyme Disease, COPD, Localized Injury, Back Pain, Alzheimer’s/Dementia, Epilepsy/Seizure Disorders, Erectile Dysfunction, Infertility (male & female), etc.

Tesla BioHealing, Inc., August 10, 2023
Read the FDA letter

Improves memory and mood in Alzheimer’s patients

Moorish Science Temple, The Divine and National Movement of North America, Inc; #13 The Moorish American National Republic dba Moor Herbs, Inc., August 1, 2023
Read the FDA letter

Reduces Risk for Dementia/Alzheimer’s

Spartan Enterprises Inc. dba Watershed Wellness Center, March 8, 2023
Read the FDA letter

Learn more about how ApelinDx™ supports ARDS and Alzheimer’s research (link in bio).

Thriftmaster Texas, LLC. d/b/a ThriftMaster Global Holdings, Inc. and TM Global Biosciences, LLC, December 5, 2022
Read the FDA letter

Tests performed on mice show CBD helping to reduce acute anxiety... and even reduced symptoms that can lead to dementia and Alzheimer’s.

Newhere Inc dba CBDFX, November 16, 2022
Read the FDA letter

Reduces oxidative damage associated with Alzheimer's disease

Conners Clinic, November 7, 2022
Read the FDA letter

What does CBD oil support?... addiction... Alzheimer’s... anxiety... chronic pain... depression... diabetes... drug withdrawal... epilepsy... glaucoma... inflammation... insomnia... Parkinson’s... sleep disorders... plus more!... Coming Soon, Young Living CBD Oil

Young Living Essential Oils Corporate, June 10, 2022
Read the FDA letter

The dementia-related conditions that can be helped by CBD Oil include Alzheimer’s disease, Vascular Dementia, Dementia with Lewy bodies (DLB), Parkinson’s disease, Frontotemporal dementia and Huntington’s disease.

BioMD Plus LLC, May 4, 2022
Read the FDA letter

Ginger: may … protect against Alzheimer’s

CAJ Food Products Inc., March 11, 2022 Closeout letter on file
Read the FDA letter

…here’s what I think how eating broccoli sprouts all these years has prevented me from having Alzheimer’s…

Sunny Creek Farm, Inc., February 2, 2022 Closeout letter on file
Read the FDA letter

Showing the 20 most recent. See every match in the free check.

Why FDA quotes wording like this

Warning letters quote a company's own marketing as evidence of how a product is being sold. Under the Federal Food, Drug, and Cosmetic Act, a product promoted to cure, treat, mitigate or prevent disease is a drug, so disease claims on a supplement, CBD or wellness product can make it an unapproved drug. Some letters quote wording like "FDA approved" or "clinically proven" for other reasons. Each letter states its own charges, so read the source before deciding anything.

This page is informational and is not legal advice.

Is "Alzheimer's" anywhere on your website?

FDA letters quote blog posts, FAQ answers and social captions, not just product pages. Our $39.99 report checks every page of your site against every letter in our database, with a link to each match.